Summary Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others. It also develops recombinant DNA protein (rDNA) products and plasma derived products for oncology, auto-immune, ophthalmology, nephrology, and plasma derived product based therapies. It has nine formulation manufacturing facilities and two active pharmaceutical ingredient (API) and intermediate facilities in India. The company markets its products globally through internal sales force and a network of distributors. Intas is headquartered in Ahmedabad, Gujarat, India. Intas Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers... Research Beam Model: Research Beam Product ID: 1916528 250 USD New
Intas Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Intas Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 27
  • Publisher : GlobalData
 
 
 
Summary

Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others. It also develops recombinant DNA protein (rDNA) products and plasma derived products for oncology, auto-immune, ophthalmology, nephrology, and plasma derived product based therapies. It has nine formulation manufacturing facilities and two active pharmaceutical ingredient (API) and intermediate facilities in India. The company markets its products globally through internal sales force and a network of distributors. Intas is headquartered in Ahmedabad, Gujarat, India.

Intas Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Teva Pharma Sells Assets and Operations of Actavis Generics in UK and Ireland to Accord Healthcare 11
Intas Pharma to Acquire Gujarat-based Biotechnology Unit of RPG Life Sciences for USD3.7 Million 12
Intas Pharma Acquires Hospital Business of Combino Pharm 13
Private Equity 14
Capital International Acquires 3% Stake in Intas Pharma from ChrysCapital for USD106 Million 14
Temasek Acquires 10.16% Stake in Intas Pharma for USD143 Million 15
ChrysCapital Acquires Additional 7.5% Stake In Intrys Phrama For US$56.1 Million 16
ChrysCapital Acquires Additional 2.53% Stake In Intas Pharma For US$56 Million 17
Partnerships 18
Albany Molecular Research Enters into Agreement with Grupo Ferrer and Accord Healthcare 18
Licensing Agreements 18
Mayne Pharma Group Enters Into Licensing Agreement With Intas Pharma For Injectable Products 18
Phosphagenics Enters Into Licensing Agreement With Intas Pharma For Anti-Ageing Products 19
Equity Offering 20
Intas Pharma Files Registration Statement For IPO To Raise Up To US$200 Million 20
Intas Pharmaceuticals Ltd - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Intas Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Teva Pharma Sells Assets and Operations of Actavis Generics in UK and Ireland to Accord Healthcare 11
Intas Pharma to Acquire Gujarat-based Biotechnology Unit of RPG Life Sciences for USD3.7 Million 12
Intas Pharma Acquires Hospital Business of Combino Pharm 13
Capital International Acquires 3% Stake in Intas Pharma from ChrysCapital for USD106 Million 14
Temasek Acquires 10.16% Stake in Intas Pharma for USD143 Million 15
ChrysCapital Acquires Additional 7.5% Stake In Intrys Phrama For US$56.1 Million 16
ChrysCapital Acquires Additional 2.53% Stake In Intas Pharma For US$56 Million 17
Albany Molecular Research Enters into Agreement with Grupo Ferrer and Accord Healthcare 18
Mayne Pharma Group Enters Into Licensing Agreement With Intas Pharma For Injectable Products 18
Phosphagenics Enters Into Licensing Agreement With Intas Pharma For Anti-Ageing Products 19
Intas Pharma Files Registration Statement For IPO To Raise Up To US$200 Million 20
Intas Pharmaceuticals Ltd, Key Competitors 22
Intas Pharmaceuticals Ltd, Key Employees 23
Intas Pharmaceuticals Ltd, Other Locations 24
Intas Pharmaceuticals Ltd, Subsidiaries 25List of Figures
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter